Peter D. Visalli advises clients across a range of transactional and general corporate matters, including mergers and acquisitions, joint venture and other collaboration arrangements, capital markets and other capital-raising transactions, and governance matters. He also advises companies with respect to SEC regulations, compliance issues and other corporate and securities law matters, such as public reporting, Sarbanes-Oxley compliance and communications with analysts and investors.
In his M&A practice, Pete’s experience includes buy-side and sell-side transactions and his clients have included public and private acquirers and targets, as well as both strategic and financial buyers. He also advises start-up and early-stage companies on a variety of matters. He serves clients across a number of industries, including the technology, gaming, life sciences, consumer products, energy, financial services and manufacturing sectors.
As a member of the firm’s Gaming Industry Group, Pete has represented casino operators, gaming manufacturers, sports wagering companies, investors and other participants in the gaming industry in a variety of transactional matters. Pete is also a member of the firm’s Private Equity industry group and has represented sponsors and portfolio companies in connection with acquisitions and dispositions and other matters.
Prior to entering the legal profession, Pete was a consultant with Capgemini, a French multinational information technology services and consulting company. Pete is a 2005 graduate of Rutgers University School of Law-Camden and a graduate of Loyola University Maryland (M.B.A., 2000; B.B.A., 1998).
Areas of Practice
- Corporate Law
- Equity and Debt Offerings
- Mergers and Acquisitions
- Securities Law
Representative Matters
Represented IQVIA Inc. (NYSE: IQV), a leading global provider of advanced analytics technology solutions and clinical research services to the life sciences industry, in connection with its acquisition of all of the membership interests of a leading clinical research firm engaged in conducting investigational studies for the development of new vaccines and medicines to help prevent a wide range of illnesses.
Represented Exacta Systems, LLC in the sale of the company to Churchill Downs, Inc. for $250 million.
Represented IQVIA Inc. (NYSE: IQV), a leading global provider of advanced analytics technology solutions and clinical research services to the life sciences industry, in connection with its acquisition of all of the membership interests of a full service medical communications agency.
Advised CMS Technologies, Inc. dba Prevenio®, a leading provider of innovative food safety solutions primarily for protein and produce industries, in its $170 million acquisition by JBT Corporation (NYSE: JBT), a global technology solutions provider to high-value segments of the food and beverage industry.
Represented online sportsbook operator Vigtory Inc. as transaction counsel in its sale to FuboTV Inc. (NYSE:FUBO), a sports-focused streaming television service; this is the first time a media company in the U.S. has fully acquired and will operate a live sportsbook.
Represented DuPont (NYSE: DD), a global innovation leader with technology-based materials, in its $110 million acquisition of Evoqua’s Memcor business, which includes ultrafiltration and membrane bio-filtration technologies.
Represented DSM-Firmenich Inc., one of the world's largest producers of flavors and fragrances, in its acquisition of Natural Flavors, Inc., a producer of natural and organic flavor products.
Advised Hill International (NYSE:HIL), a Philadelphia-based project management company, in the sale of its Construction Claims Group to UK-based private equity firm Bridgepoint Development Capital for $147 million.
Represented Mannington Mills, a leading manufacturer of fine flooring, in its acquisition of Phenix Flooring and Pharr Fibers and Yarns, a leader in the flooring industry and pioneer in the solution-dyed arena, from Pharr USA.
Represented CBS Sports Digital, the second-largest sports property in the U.S., in entering into a strategic partnership with William Hill, a leading sports book operator; the partnership makes William Hill the official sports book and wagering data provider across selected CBS Sports Digital platforms.
Represented X Core Technologies, a leader in the metal smart card field, in a sale of domestic and foreign patents and patent applications to Idemia, a French multinational company specializing in security and identity solutions.
Represented JPJ Group (formerly LSE:JPJ), a leading global online bingo-led operator, in its £490m acquisition of online gaming company Gamesys Holdings Ltd., thereby forming Gamesys Group (LSE:GYS).
Represented theScore, Inc., a publicly traded digital media company, as regulatory and transactional counsel regarding agreements with Darby Development LLC, the operator of the Monmouth Park Racetrack and Betworks (US) LLC whereby theScore will offer and operate on-line and mobile sports betting throughout the state of New Jersey.
Represented DSM-Firmenich Inc., one of the world’s largest producers of flavors and fragrances, in its $80 million all-cash tender offer of U.S. public company Senomyx, Inc., a leader in taste innovation and sweet, cooling and bitter solutions (Nasdaq: SNMX).
Represented Catalent Biologics’ (NYSE: CTLT) Paragon Gene Therapy unit, the leading viral vector development and manufacturing partner for gene therapies, in its acquisition of manufacturing equipment and related assets from, and strategic partnership with, Novavax, Inc. (Nasdaq: NVAX), a late-stage biotech company developing next-generation vaccines for infectious diseases; the transaction expands Paragon’s gene therapy business and offers Novavax a cost-effective solution to its manufacturing needs.
Represented iAnthus Capital Holdings, Inc. (CSE: IAN; OTCQX: ITHUF) in its acquisition of CBD For Life, a top-ranked producer of innovative CBD-infused wellness, self-care, and beauty products.
Represented Catalent, Inc. (NYSE: CTLT), a drug delivery technology company, in its $140 million all cash acquisition via tender offer of Juniper Pharmaceuticals, Inc. (NASDAQ:JNPR), including its U.K.-based Juniper Pharma Services division.
Represented the special committee of the Board of Directors of JAVELIN Mortgage Investment Corp. (NYSE: JMI) in a merger in which ARMOUR Residential REIT, Inc. (NYSE: ARR) acquired JAVELIN for $85.2 million, with its $900 million of assets, in a cash tender offer.
Represented U.K. owned Prepaid Network Inc., an online casino company, in obtaining New Jersey approvals for a program that provides a secure way for players to load money from preferred cards into their accounts, and handled the company's formation and general corporate matters.
Represented Unilife Corp. (Nasdaq: UNIS / ASX: UNS) in connection with its announced effort to seek strategic alternatives, culminating in a strategic collaboration with Amgen Inc. (Nasdaq: AMGN) for Unilife's wearable injectable drug delivery systems to use with Amgen's biologics and other medicines. The deal provides Unilife with investments of up to $90 million from Amgen and restructures Unilife's existing debt with OrbiMed.
Represented Tropicana Entertainment Inc. in entering into a Management Agreement pursuant to which it would manage the Trump Taj Mahal Casino Hotel and provide consulting services relating to the former Plaza Hotel and Casino in Atlantic City, New Jersey. Representation also includes formation of TEI Management Services LLC and the pursuit of required gaming regulatory approvals.
Admissions
- New Jersey
Education
- Rutgers Law School, J.D., 2005
- Loyola College, M.B.A., 2000
- Loyola College, B.B.A., 1998